Portfolio company
Molecule One
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops an artificial intelligence platform for chemical synthesis planning and molecule discovery for pharmaceutical and biotechnology organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Denovo Sciences
This company develops an AI-driven platform for structure-based drug discovery to provide small-molecule candidates for pharmaceutical and biotechnology organisations.
Anagenex
This company develops a machine learning and biochemistry platform to identify and optimise small molecule drug candidates for pharmaceutical and biotechnology organisations.
DeepMirror AI
This company provides a drug design platform that uses machine learning to help medicinal chemists identify and optimise molecules for biopharmaceutical research.
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
Valence Discovery
This company provides a machine learning platform for molecular design and lead optimisation to pharmaceutical and biotechnology firms.
Capsule AI
This company develops autonomous agent systems that conduct scientific research and strategic analysis for pharmaceutical and biotechnology organisations.
